CVS HEALTH CORP (CVS.DE) Stock Analyst Earnings Estimates
FRA:CVS - Deutsche Boerse Ag - US1266501006 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 322.467B 10.39% | 357.776B 10.95% | 372.809B 4.20% | 390.682B 4.79% | 406.428B 4.03% | 430.891B 6.02% | 458.255B 6.35% | 466.394B 1.78% | 452.074B -3.07% | 476.624B 5.43% | 502.144B 5.35% | |
| EBITDA YoY % growth | N/A 3.28% | N/A 0.50% | N/A -27.63% | 16.407B 11.23% | 17.996B 9.68% | 19.522B 8.48% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 16.29B 6.95% | 15.086B -7.39% | 10.038B -33.46% | 13.776B 37.24% | 15.257B 10.75% | 16.183B 6.07% | 19.168B 18.45% | 18.837B -1.73% | N/A | N/A | N/A | |
| Operating Margin | 5.05% | 4.22% | 2.69% | 3.53% | 3.75% | 3.76% | 4.18% | 4.04% | N/A | N/A | N/A | |
| EPS YoY % growth | 8.70 3.45% | 8.74 0.46% | 5.42 -37.99% | 6.20 14.30% | 7.09 14.50% | 8.08 13.90% | 9.44 16.79% | 9.97 5.68% | 9.02 -9.55% | 9.68 7.28% | 10.38 7.31% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.42 30.10% | 0.97 -18.62% | 2.30 2.19% | 1.79 -1.34% | 1.98 39.79% | 1.42 46.62% | 1.76 -23.57% | 2.24 25.57% | 2.47 24.58% | 1.46 2.79% |
| Revenue Q2Q % growth | 98.864B 3.60% | 101.703B 4.09% | 97.744B 3.34% | 102.034B 3.15% | 106.024B 7.24% | 108.926B 7.10% | 103.946B 6.35% | 106.951B 4.82% | 111.678B 5.33% | 114.9B 5.48% |
| EBITDA Q2Q % growth | 3.857B 0.78% | 3.116B 4.49% | 5.479B 26.57% | 4.384B 12.73% | 4.619B 19.76% | 4.18B 34.15% | 3.846B -29.80% | 4.982B 13.64% | 5.678B 22.93% | 4.368B 4.50% |
| EBIT Q2Q % growth | 3.223B 61.07% | 2.451B -1.09% | 4.775B 41.52% | 3.858B 62.03% | 4.041B 25.38% | 3.058B 24.77% | 3.635B -23.87% | 4.416B 14.46% | 4.768B 17.99% | 3.071B 0.43% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.81 -1.09% | 1.47 | 0.34 | 22.99% |
| Q1 2025 Q2Q % growth | 2.25 71.76% | 1.72 | 0.53 | 30.76% |
| Q4 2024 Q2Q % growth | 1.19 -43.87% | 0.94 | 0.25 | 27.26% |
| Q3 2024 Q2Q % growth | 1.09 -50.68% | 1.52 | -0.43 | -28.40% |
| Q2 2024 Q2Q % growth | 1.83 -17.19% | 1.75 | 0.08 | 4.69% |
| Q1 2024 Q2Q % growth | 1.31 -40.45% | 1.71 | -0.40 | -23.44% |
| Q4 2023 Q2Q % growth | 2.12 6.53% | 2.01 | 0.11 | 5.45% |
| Q3 2023 Q2Q % growth | 2.21 5.74% | 2.16 | 0.05 | 2.51% |
| Q2 2023 Q2Q % growth | 2.21 -7.92% | 2.13 | 0.08 | 3.81% |
| Q1 2023 Q2Q % growth | 2.20 -0.90% | 2.11 | 0.09 | 4.28% |
| Q4 2022 Q2Q % growth | 1.99 0.51% | 1.94 | 0.05 | 2.46% |
| Q3 2022 Q2Q % growth | 2.09 6.09% | 2.01 | 0.08 | 3.87% |
| Q2 2022 Q2Q % growth | 2.40 -0.83% | 2.20 | 0.20 | 9.31% |
| Q1 2022 Q2Q % growth | 2.22 8.82% | 2.18 | 0.04 | 2.05% |
| Q4 2021 Q2Q % growth | 1.98 52.31% | 1.95 | 0.03 | 1.58% |
| Q3 2021 Q2Q % growth | 1.97 18.67% | 1.80 | 0.17 | 9.72% |
| Q2 2021 Q2Q % growth | 2.42 -8.33% | 2.08 | 0.34 | 16.07% |
| Q1 2021 Q2Q % growth | 2.04 6.81% | 1.73 | 0.31 | 17.77% |
| Q4 2020 Q2Q % growth | 1.30 -24.86% | 1.25 | 0.05 | 4.07% |
| Q3 2020 Q2Q % growth | 1.66 -9.78% | 1.34 | 0.32 | 23.54% |
| Q2 2020 Q2Q % growth | 2.64 39.68% | 1.95 | 0.69 | 35.54% |
| Q1 2020 Q2Q % growth | 1.91 17.90% | 1.64 | 0.27 | 16.24% |
| Q4 2019 Q2Q % growth | 1.73 | 1.70 | 0.03 | 1.78% |
| Q3 2019 Q2Q % growth | 1.84 | 1.79 | 0.05 | 2.99% |
| Q2 2019 Q2Q % growth | 1.89 | 1.71 | 0.18 | 10.46% |
| Q1 2019 Q2Q % growth | 1.62 | 1.52 | 0.10 | 6.73% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 98.915B 8.42% | 95.444B | 3.471B | 3.64% |
| Q1 2025 Q2Q % growth | 94.588B 6.96% | 94.572B | 16M | 0.02% |
| Q4 2024 Q2Q % growth | 97.71B 4.15% | 98.16B | -450M | -0.46% |
| Q3 2024 Q2Q % growth | 95.428B 6.31% | 93.674B | 1.754B | 1.87% |
| Q2 2024 Q2Q % growth | 91.234B 2.60% | 92.411B | -1.177B | -1.27% |
| Q1 2024 Q2Q % growth | 88.437B 3.70% | 90.101B | -1.664B | -1.85% |
| Q4 2023 Q2Q % growth | 93.813B 11.89% | 91.309B | 2.504B | 2.74% |
| Q3 2023 Q2Q % growth | 89.764B 10.60% | 89.137B | 627M | 0.70% |
| Q2 2023 Q2Q % growth | 88.921B 10.27% | 87.398B | 1.523B | 1.74% |
| Q1 2023 Q2Q % growth | 85.278B 11.00% | 81.622B | 3.656B | 4.48% |
| Q4 2022 Q2Q % growth | 83.846B 9.45% | 76.971B | 6.875B | 8.93% |
| Q3 2022 Q2Q % growth | 81.159B 9.98% | 77.519B | 3.64B | 4.70% |
| Q2 2022 Q2Q % growth | 80.636B 11.04% | 77.133B | 3.503B | 4.54% |
| Q1 2022 Q2Q % growth | 76.826B 11.19% | 76.146B | 680M | 0.89% |
| Q4 2021 Q2Q % growth | 76.604B 10.14% | 76.428B | 176M | 0.23% |
| Q3 2021 Q2Q % growth | 73.794B 10.05% | 71.19B | 2.604B | 3.66% |
| Q2 2021 Q2Q % growth | 72.616B 11.13% | 71.002B | 1.614B | 2.27% |
| Q1 2021 Q2Q % growth | 69.097B 3.51% | 69.071B | 26M | 0.04% |
| Q4 2020 Q2Q % growth | 69.554B 3.98% | 69.434B | 120M | 0.17% |
| Q3 2020 Q2Q % growth | 67.056B 3.47% | 67.329B | -273M | -0.41% |
| Q2 2020 Q2Q % growth | 65.341B 3.01% | 64.87B | 471M | 0.73% |
| Q1 2020 Q2Q % growth | 66.755B 8.29% | 64.74B | 2.015B | 3.11% |
| Q4 2019 Q2Q % growth | 66.889B | 64.61B | 2.279B | 3.53% |
| Q3 2019 Q2Q % growth | 64.81B | 63.617B | 1.193B | 1.88% |
| Q2 2019 Q2Q % growth | 63.431B | 63.277B | 154M | 0.24% |
| Q1 2019 Q2Q % growth | 61.646B | 60.995B | 651M | 1.07% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.51% | -13.26% | 0% | 3.9% |
| Revenue | 0.17% | -0.96% | -0.06% | -0.68% |